18F-FDG/PET Helps Predict Prognosis of Vegetative Patients

摘要

18F-FDG PET more accurate than fMRI and may help physicians better determine the long-term recovery of patients with unresponsive wakefulness syndrome. Cerebral 18F-fluorodeoxyglucose (FDG) PET can assist in predicting the long-term recovery of patients with unresponsive wakefulness syndrome, according to a study published in The Lancet. Researchers from Belgium, Canada, and Denmark performed a clinical validation study to test the diagnostic accuracy of functional 18F-FDG PET and functional MRI (fMRI) in clinical practice.